Intest Res.  2015 Jan;13(1):2-3. 10.5217/ir.2015.13.1.2.

A Clinical Significance of Assessing Cytomegalovirus Infection Status in Patients With Ulcerative Colitis

• Chang S
• Cheon JH

• KMID: 1807369
• DOI: http://doi.org/10.5217/ir.2015.13.1.2

Abstract

No abstract available.

MeSH Terms

Colitis, Ulcerative*
Cytomegalovirus Infections*
Humans

Reference

1. Cohen JI, Corey GR. Cytomegalovirus infection in the normal host. Medicine (Baltimore). 1985; 64:100–114. PMID: 2983175.

2. Montejo M. Key definitions and concepts in cytomegalovirus: infection versus disease. Replication, viral load, universal prophylaxis. Preemptive therapy. Enferm Infecc Microbiol Clin. 2011; 29(Suppl 6):4–5. PMID: 22541914.

3. Kommareddy S, Chun CL, Rogers W, Triadafilopoulos G. Always a suspect: CMV in ulcerative colitis. Dig Dis Sci. 2013; 58:1838–1840. PMID: 23306856.

4. Kim JJ, Simpson N, Klipfel N, Debose R, Barr N, Laine L. Cytomegalovirus infection in patients with active inflammatory bowel disease. Dig Dis Sci. 2010; 55:1059–1065. PMID: 20112061.

5. Kim JW, Boo SJ, Ye BD, et al. Clinical utility of cytomegalovirus antigenemia assay and blood cytomegalovirus DNA PCR for cytomegaloviral colitis patients with moderate to severe ulcerative colitis. J Crohns Colitis. 2014; 8:693–701. PMID: 24405983.

6. Jang EY, Park SY, Lee EJ, et al. Diagnostic performance of the cytomegalovirus (CMV) antigenemia assay in patients with CMV gastrointestinal disease. Clin Infect Dis. 2009; 48:e121–e124. PMID: 19441977.

7. Kim YS, Kim YH, Kim JS, et al. Long-term outcomes of cytomegalovirus reactivation in patients with moderate to severe ulcerative colitis: a multicenter study. Gut Liver. 2014; 8:643–647. PMID: 25368753.

8. Kim YS, Kim YH, Kim JS, et al. The prevalence and efficacy of ganciclovir on steroid-refractory ulcerative colitis with cytomegalovirus infection: a prospective multicenter study. J Clin Gastroenterol. 2012; 46:51–56. PMID: 21552140.

9. Chun JY, Lee CH, Kwon JE, et al. Usefulness of the cytomegalovirus antigenemia assay in patients with ulcerative colitis. Intest Res. 2015; 13:50–59.

10. Park SH, Yang SK, Hong SM, et al. Severe disease activity and cytomegalovirus colitis are predictive of a nonresponse to infliximab in patients with ulcerative colitis. Dig Dis Sci. 2013; 58:3592–3599. PMID: 23979435.